Key result
A 39-year-old immunosuppressed renal transplant recipient developed a clinically aggressive angiosarcoma at an arteriovenous fistula site that clinically mimicked a thrombosed aneurysm.
Case Report (n=1)
Highlights the rare occurrence of aggressive angiosarcoma at arteriovenous fistula sites in immunosuppressed renal transplant patients.
Clinicians should consider malignancy in atypical AVF masses in immunosuppressed transplant recipients; extends sparse case reports but remains hypothesis-generating.
Angiosarcoma in the setting of immunosuppressed renal transplant recipients is exceedingly rare. In this report, we describe the occurrence of angiosarcoma arising at an arteriovenous fistula site of a 39-year-old renal transplant recipient that clinically mimicked a thrombosed aneurysm. These tumors are histologically high-grade and clinically aggressive malignancies. They have a predilection for arteriovenous fistula sites. The literature on this uncommon entity is reviewed and possible histogenesis is discussed.
No takes yet. Share an insight, caveat, or question.
Farag et al. (2005) conducted a case report in Angiosarcoma at an arteriovenous fistula site (n=1). Arteriovenous fistula and immunosuppression was evaluated on Occurrence of angiosarcoma. A 39-year-old immunosuppressed renal transplant recipient developed a clinically aggressive angiosarcoma at an arteriovenous fistula site that clinically mimicked a thrombosed aneurysm.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: